Merck’s Shares Look Undervalued
A version of this article appeared on Seeking Alpha’s website: https://seekingalpha.com/article/280602-mercks-shares-look-undervalued As part of our process, we employ a discounted cash-flow model to arrive at a fair value estimate for every company within our equity coverage universe. In Merck’s (MRK) case, we think using a discounted cash-flow model is the best tool for valuation. We outline below our valuation summary for Merck and offer up our model template to investors if they are interested in using it to value any operating (non-financial) company they wish. This model template can be found at DCF Valuation Model Template. Valuation Summary We think Merck’s shares are worth $43 each based on our discounted cash-flow process. We’re forecasting revenue expansion in the low-double-digits for fiscal … Read more